6 min read
2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress
2021 – A true testimony that we sit at the intersection of significant new opportunities The significant opportunities at the intersection of
Tag : Illumina
6 min read
6 min read
Merger Control’s Misaligned Incentives
Antitrust policymakers around the world have taken a page out of the Silicon Valley playbook and decided to “move fast and break things.” While
Rebus Bio Continues Expansion of Industry-leading Spatial Omics Platform with Breakthrough High-Plex Technology
EEL assay overcomes well-known limitations in spatial biology SANTA CLARA, Calif. & STOCKHOLM–(BUSINESS WIRE)–Rebus Biosystems Inc, (“Rebus
1 min read
Bionano Genomics Acquiring BioDiscovery – The Perfect Alignment of the Stars
One of October’s headlines in the field of genomics and genetics included the acquisition of BioDiscovery by Bionano Genomics. I spoke with
Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease
The iHope Genetic Health program will expand access to whole-genome sequencing to low- and middle-income communities around the world, with more than
1 min read
ESG in Genomics: Where to start? – Interview with Sharon Vidal, Senior Director and Global Lead for Corporate Social Responsibility at Illumina
Recently, I wrote a blog about the importance of Environmental, Social and Corporate Governance (ESG) and why the genomics industry should be taking
1 min read
Eight Tips and Takeaways for Pivoting From Virtual to In-person Events
If you didn’t produce or attend a virtual event in 2020, are you really an event marketer? The industry has spent the better part of the last year
1 min read
Genetics Unzipped podcast: Reading the book of life – A brief history of DNA sequencing
Output from an ABI 373 DNA sequencer, Image courtesy of National Human Genome Research Institute In the latest Genetics Unzipped podcast, Dr Kat
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
Aug 18, 2021GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review SAN DIEGO, /PRNewswire/ — Illumina,
9 min read
Bad Blood at the FTC
John Carreyrou’s marvelous book Bad Blood chronicles the rise and fall of Theranos, the one-time Silicon Valley darling that was revealed to be a
5 min read
Illumina Vows to Fight Back as FTC Takes Aim at $8B Grail Acquisition
Rebecca Kelly Slaughter, Acting Chairwoman of the U.S. Federal Trade Commission (FTC) The U.S. Federal Trade Commission (FTC) said it will challenge
2 min read
Featured RNA-Seq Job – Staff Bioinformatics Scientist, RNA-Seq
Position Summary: Our engineering team specializes in developing a fast and accurate FPGA-accelerated platform called DRAGEN, for the secondary
5 min read
Enlightenbio Releases New Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics
New, qualitive report provides an in-depth analysis across the complex, multi-step clinical genomics data process, including genomic data generation
6 min read
Illumina v MGI Part 1: Mr Justice Birss on sufficiency, DNA sequencing and chocolate teapots
The High Court decision in Illumina v MGI ([2021] EWHC 57 (Pat)) is the first to take an in depth look at the thorny issue of sufficiency since last
3 min read
Illumina, Emedgene Launch AI-Based Rare Disease Interpretation Partnership
Illumina has launched a nonexclusive partnership with Emedgene, an artificial intelligence-based precision medicine company, to integrate automated